These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24697180)

  • 21. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
    Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
    Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
    Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
    Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
    Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation and quality evaluation of microcapsules of volatile oil from Ledum palustre].
    Lv M
    Zhong Yao Cai; 2014 Apr; 37(4):675-8. PubMed ID: 25345143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
    Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S; Lohan S; Murthy RS
    Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel lectin-modified poly(ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design.
    Varshosaz J; Moazen E
    Pharm Dev Technol; 2014 Aug; 19(5):605-17. PubMed ID: 23937559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir.
    Perret F; Duffour M; Chevalier Y; Parrot-Lopez H
    Eur J Pharm Biopharm; 2013 Jan; 83(1):25-32. PubMed ID: 23072941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation.
    Lee EJ; Khan SA; Park JK; Lim KH
    Bioprocess Biosyst Eng; 2012 Jan; 35(1-2):297-307. PubMed ID: 21909678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A; Al-Kassas R
    Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir.
    Bhosale U; Kusum DV; Jain N
    J Young Pharm; 2011 Oct; 3(4):275-83. PubMed ID: 22224033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability.
    Hasanovic A; Zehl M; Reznicek G; Valenta C
    J Pharm Pharmacol; 2009 Dec; 61(12):1609-16. PubMed ID: 19958582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
    Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis.
    Sultana S; Talegaonkar S; Ali R; Mittal G; Ahmad FJ; Bhatnagar A
    J Microencapsul; 2012; 29(5):445-54. PubMed ID: 22292965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
    Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
    Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride.
    Park SJ; Choo GH; Hwang SJ; Kim MS
    Arch Pharm Res; 2013 May; 36(5):593-601. PubMed ID: 23446651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.